: Pacliavenir. ?  »
|
-

I.V

Solution For Injection

Paclitaxel is indicated alone or in combination, for the treatment of advanced carcinoma of the ovary. For the treatment of metastatic breast cancer after failure of combination chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. Advanced non small cell lung cancer: Paclitaxel, associated with cisplatium is indicated for the treatment of non small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy. Keposi`s sarcoma: Paclitaxel is indicated in the second- line treatment of AID`S related Kaposi`s sarcoma.Paclitaxel is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy.For the treatment of advanced gastric carcinoma.

130 89 30941 00

Biolyse Pharma Corporation, Canada

05/2014 - 05/2024

.
, .
.
/
Paclitaxel 6 MG/ML
Vial glass type i 4 x 50 ML 24
Vial glass type i 10 x 5 ML 24
Vial glass type i 5 x 16.7 ML 24

*

*

 

.

...
 »
 
" !
 
301
-